Device Can Read Genetic Signature Of Circulating Tumour Cells To Guide Therapy
Jul 16th 2008Drug InformationCancer
A microchip-based device that detects and analyses tumour cells in the bloodstream proved effective in determining the genetic signature of lung tumours, allowing identification of patients appropriate for targeted treatment in a pilot study in patients with non-small-cell lung cancer (NSCLC).
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
